Evaluation of restaging in clinical stage 1A low malignant potential ovarian tumours

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 4, 2002, Pages 381-384

  Land, Russell ^a   Perrin, Lew ^a   Nicklin, James ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; EVALUATION; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MORBIDITY; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SECOND LOOK SURGERY;

EID: 0036817745     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.00381.x     Document Type: Article

References (17)

1. Taylor HC. Malignant and Semimalignant tumours of the ovary. Surg Gynecol Obstet. 1929; 48: 204-230.
2. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand. 1971; 50 (1): 1-7.
3. Kottmeier HL, Kolstad P, McGarrity KA, et al. Annual report on results of treatment in gynecologic cancer. v.17. Stockholm: Radiumhemmet Editorial Office; 1973.
4. Aure JC, Hoeg K, Kolstad P. Clinical and histologic studies of ovarian carcinomas. Long term follow-up of 990 cases. Obstet Gynecol. 1971 Jan: 37 (1): 1-9.
5. Morrow CP, Townsend DE. Treatment of Borderline Ovarian Malignancies: Synopsis of Gynecologic Oncology. 3rd edition. New York: Churchill Livingstone, 1987: 262.
6. Snider DD, Stuart GCE, Nation JG, Robertson DI. Evaluation of surgical staging in stage 1 low malignant potential ovarian tumours. Gynecol Oncol. 1991 Feb; 40 (2): 129-132.
7. Hopkins MP, Morley GW. The second-look operation and surgical reexploration in ovarian tumour of low malignant potential. Obstet Gynecol. 1989 Sep; 74 (3 Pt 1): 375-378.
8. Ehlen TG and members of the SOGC/GOC/SCC Policy and Practice Guideline Committee: Management of low malignant potential tumour of the ovary: J Soc Obstet Gynaecol Can. 2000; 22 (1): 19-21.
9. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000 May; 31(5): 539-557.
10. Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Retropertioneal lymphatic involvement with epithelial ovarian tumours of low malignant potential. Gynecol Oncol. 1991 Aug, 42 (2): 124-130.
11. Yazigi R, Sanstad J, Munoz AK. Primary staging in ovarian tumours of low malignant potential. Gynecol Oncol. 1988 Nov; 31 (3): 402-408.
12. Kaern J, Trope CG, Abelar VM. A retrospective study of 370 borderline tumours of the ovary treated at The Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer. 1993 Mar; 71 (5): 1810-1820.
13. Trope CG, Kristensen G, Makar A. Surgery for borderline tumour of the ovary. Semin Surg Oncol. 2000 Jul-Aug; 19 (1): 69-75.
14. Bell DA. Ovarian surface epithelial-stromal tumours. Hum Pathol. 1991 Aug: 22 (8): 750-762.
15. Copeland LJ, Silva EG, Gershenson DM, Sneige N, Atkinson EN, Wharton JT. The significance of Müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms. Obstet Gynecol. 1988 May; 71 (5): 763-770.
16. Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, Kucera PR, Roman LD. Preliminary analysis of the behaviour of stage 1 ovarian serous tumours of low malignant potential : a Gynecologic Oncology Group study. J Clin Oncol. 1995 Nov; 13 (11): 2752-2756.
17. Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumours: a follow up study of 35 cases. Obstet Gynecol. 1988 Nov; 72 (5): 775-781.